Records containing: Stage IV Endometrial Carcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2020-08-17
Sentinel Lymph Node Mapping for Endometrial Cancer
CLINICAL_TRIALS study record update · 2016-06-13
Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.
CLINICAL_TRIALS study record update · 2015-05-21
A Phase II Evaluation of Ixabepilone (BMS-247550) [NCI-Supplied Agent, NSC #710428]) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
CLINICAL_TRIALS study record update · 2014-06-19
Phase I Study of CCI-779 (NSC 683864) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumours
CLINICAL_TRIALS study record update · 2014-05-30
Safety and Efficacy of RO4929097 in Combination With Temsirolimus: A Pharmacokinetic and Pharmacodynamic Phase I Study in Patients With Advanced Solid Tumours With an Expansion of Cohort With Patients With Recurrent/Metastatic Endometrial and Renal Cell Cancers
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2013-11-28
A Prospective Evaluation of a Palliative Radio-Surgical Approach for the Treatment of Gynecologic Malignancies
CLINICAL_TRIALS study record update · 2013-09-30
A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II)
CLINICAL_TRIALS study record update · 2013-02-28
A Phase I Trial of Herceptin and Interleukin-12
CLINICAL_TRIALS study record update · 2013-01-16
Evaluation of Hypoxia by EF5 Binding in Gynecologic Cancer